| 标题 |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Véronique Dièras; David Miles; Sunil Verma; Mark D. Pegram; Manfred Welslau; et al 出版日期:2017-05-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)